Document is current
Any future updates will be listed below
-
Authors
Jin, Yongchen
Zhang, Yishan
Wang, Mingshuai
Bai, Xiaoxuan
Ping, Hao
Xing, Nianzeng
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82072833 and No. 82272864, No. 82072833 and No. 82272864, No. 82072833 and No. 82272864, No. 82072833 and No. 82272864, No. 82072833 and No. 82272864, No. 82072833 and No. 82272864)
Capital’s Funds for Health Improvement and Research (No. 2024-2-2059, No. 2024-2-2059, No. 2024-2-2059, No. 2024-2-2059, No. 2024-2-2059, No. 2024-2-2059)
- License Information
-
More Information
Article History
Received: 22 February 2025
Accepted: 11 August 2025
First Online: 30 September 2025
Declarations
:
: Institutional review board approval was waived for this study because FAERS is a public anonymized database.
: Data that support the findings of this study is obtained from the FDA Adverse Event Reporting System (FAERS) database that was provided by the FDA. No individual patient consent was required for the publication of this study.
: The authors declare no competing interests.
